● The company has solid fundamentals for a short-term investment strategy.
Strengths
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● The stock, which is currently worth 2020 to 0.07 times its sales, is clearly overvalued in comparison with peers.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company has insufficient levels of profitability.
● The company's earnings releases usually do not meet expectations.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● Analysts covering the stock have recently lowered their earnings forecast.
● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
● For the past year, analysts have significantly revised downwards their profit estimates.
● The underlying tendency is negative on the weekly chart below the resistance at 16.9 EUR